NOF CORPORATION (4403) Stock Price

NOF Corporation operates three main business segments: functional chemicals, pharmaceuticals/medical/health products, and chemical products. In addition, the company engages in other businesses including transportation and real estate through its subsidiaries and affiliated companies.

The functional chemicals segment manufactures and sells fatty acids and their derivatives, surfactants, ethylene oxide and propylene oxide derivatives, organic peroxides, petrochemicals, functional polymers, and electronic materials. Key affiliated companies include NOF Industrial Co., Ltd. and Changshu NOF Chemical Co., Ltd.

The pharmaceuticals, medical, and health segment handles edible processed oils and fats, food functional ingredients, health-related products, biocompatible materials, and drug delivery system (DDS) pharmaceutical raw materials. NOF Trading Co., Ltd. and NOF AMERICA CORPORATION serve as affiliated sales companies in this segment.

The chemical products segment provides industrial explosives, space-related products, defense-related products, and functional products. Nippon Koki Co., Ltd. and NOF Technical Research Institute handle manufacturing and sales, while JAPEX and Nippon Kogyo Co., Ltd. manage sales operations.

Other business operations include transportation services handled by Nichiyu Logistics and real estate services managed by NOF Trading Co., Ltd. Through this diversified business portfolio, NOF Corporation addresses a wide range of market needs.

Nichi-Yu aims for sustainable growth under its management philosophy: "As a chemical company group creating new value from biology to space, we contribute to people and society." To realize this vision, the company prioritizes three core values—"Challenge," "Fairness," and "Harmony"—placing them at the center of business operations and organizational management.

The company actively allocates management resources across three business domains: Life & Healthcare, Environment & Energy, and Electronics & Information. It seeks to establish a sustainable revenue base for long-term growth while fulfilling corporate social responsibility through enhanced safety, environmental conservation, quality management, and compliance.

Under its "2025 Medium-Term Management Plan" (fiscal year 2023 as the first year), the company adopts "Practice and Advancement" as its basic policy. Key initiatives include capturing market changes for business expansion, accelerating new product and technology development, improving productivity, pursuing safety and security, and promoting CSR. These efforts aim to realize a secure and prosperous society.

Specific initiatives include expanding cosmetic ODM production lines at the Aichi facility and establishing new manufacturing equipment for DDS pharmaceutical formulation raw materials. The company accelerates new product and technology development in functional chemical materials and medical device materials through open innovation. It also promotes productivity improvements via digital transformation.

For CSR promotion, the company has identified 11 materiality items related to sustainability. It advances the provision of new value toward a prosperous and sustainable society, strengthens business foundations, and promotes Responsible Care activities. These efforts aim to build a resilient corporate structure with international competitiveness.